Oncodesign Services

Biotechnology ResearchBourgogne-Franche-Comté, France51-200 Employees

Oncodesign Services is a preclinical contract research organization in the biotechnology research sector, based in Dijon, France (20 Rue Jean Mazen bp 27627 Dijon, Bourgogne-franche-comté France). The company specializes in advanced development programs in targeted radiotherapy, oncology, immuno-oncology, and inflammation and autoimmune diseases, focusing on the translational phase of drug development to support progression toward IND and clinical development. Its services cover the preclinical path from early candidate through IND-enabling studies, addressing challenges such as radionuclide supply, biodistribution imaging, dosing strategy, and translational relevance, with integrated imaging to support longitudinal assessment of pharmacological effects, biodistribution, and target engagement. The organization has more than 30 years of experience in preclinical oncology, over 20 years in imaging, and more than 10 years in inflammatory disease and radiopharmaceutical development, and its facilities are AAALAC-accredited. Recent developments include the acquisition of ZoBio BV in January 2024 and partnerships with ImaginAb in 2023, and the appointment of Aidan Synnott as chief executive officer in 2025.

Sign up for free to view info

Email Format Employee directory